Medical Grade Silicone Market Expected To Trigger A Revenue Increase To USD 596.8 Million By 2025

San Francisco, 24 December 2018, Medical Grade Silicone Market Analysis By Product (Elastomers, Gels, Medical Adhesives, Medical Coatings, Foams), By Application (Prosthetics, Orthopedic, Contact Lens), And Segment Forecasts, 2018 - 2025

The global medical grade silicone market is expected to reach USD 596.8 million by 2025, growing at a CAGR of 6.6%, according to a report by Grand View Research, Inc. Rising demand for Medical Grade Silicone owing to its inherent thermal and chemical stability, hydrophobicity, resistance to sterilization method, and low surface tension is expected to augment the industry size over the forecast period.

The growing use of high consistency silicone elastomers due to various properties offered such as green strength, which is necessary to maintain extruded profiles until vulcanized, is expected to increase their demand in extrusion applications, which in turn is anticipated to stimulate the demand over the forecast period.

Silicone medical adhesives are used to fabricate medical devices, seal wounds, and affix medical devices including dressing, a patch to the skin, and as a tape. The market is expected to exhibit promising gains on account of high tourist numbers triggering medical tourism in the Asia Pacific, especially in India, South Korea, Thailand, Singapore, and Malaysia.

The global medical silicone coatings market accounted for 8.7% of the overall revenue share in 2016 and is expected to witness growth on account of high usage of the product in mandrels, catheters, hypo tubes, stents, guide wires, sutures, and syringes. The growing geriatric population coupled with the rising obesity rates is anticipated to increase the occurrences of cardiac diseases, which in turn is expected to stimulate the medical silicone demand.

Access Full Research Report On Medical Grade Silicone Market  Analysis:

www.grandviewresearch.com/industry-analysis/medical-grade-silicone-market

Further key findings from the report suggest:

·         Silicone elastomer is anticipated to witness significant revenue gain with a predicted CAGR of 6.9% from 2017 to 2025 due to the rising consumption of the product in the Liquid Silicone Rubber (LSR) and High Consistency Rubber (HCR) applications. LSR and HCR find application in pump diaphragms, hydrocephalic shunts, replacement finger joints, pacemaker lead coverings, and catheters.

·         Asia Pacific was the prominent market and accounted for 22.1% of the overall volume share in 2016. Favorable FDI and “Make in India” policy implemented by the Government of India are expected to generate opportunities for the medical device components industry in the country, which in turn is likely to aid in the medical silicone industry growth.

·         Growing awareness regarding commercially available products, the adoption of enhanced surgical treatments, and increasing healthcare infrastructure are expected to open new avenues for medical products in the U.S., and therefore, augment the demand for medical silicone in the market

·         Momentive Performance Materials Inc.; 3M Company; Trelleborg AB; Primasil Silicones Limited; China National Bluestar (Group) Co. Ltd. (Bluestar); Henkel AG & Co. KGaA; Dow Corning Corporation; Zodiac Coating SAS; and Wacker Chemie AG are some of the prominent players dominating the industry

·         The global medical silicone market is highly fragmented in nature and marked by the presence of numerous global and regional silicone producers. Due to end-user opportunities and fragmented nature of the market, the intensity of rivalry is expected to increase in the next eight years.

·         In February 2017, Wacker Chemie AG named Foster Corporation as an exclusive distributor of medical-grade silicone rubber for the company’s Silpuran line in the North America healthcare market to provide services such as customer support, enhanced customer experience, and logistics in the region

·         In November 2016, Dow Corning Corp. launched soft skin adhesive to bridge the gap between the company’s Pressure Sensitive Adhesives (PSAs) and gentle-adhesion SSAs

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/bulk-chemicals

Grand View Research has segmented the Medical Grade Silicone Market on the basis of product, application, end use, and region:

Product Outlook (Volume, Tons; Revenue, USD Million; 2014 - 2025)

·         Elastomers

·         Gels

·         Medical Adhesives

·         Medical Coatings

·         Foams

·         Others

Application Outlook (Volume, Tons; Revenue, USD Million; 2014 - 2025)

·         Prosthetics

·         Orthopedic Components

·         Medical Devices

·         Medical Tapes

·         Contact Lens

·         Oral Care Products

·         Others

Regional Outlook (Volume, Tons; Revenue, USD Million; 2014 - 2025)

·         North America

o    U.S.

·         Europe

o    France

o    Germany

·         Asia Pacific

o    China

o    India

·         Central & South America

o    Brazil

·         Middle East & Africa

Access Full Press Release of this Report: 
www.grandviewresearch.com/press-release/global-medical-grade-silicone-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

Live Cell Imaging Market Expected To Trigger A Revenue Increase To USD 9.0 Billion By 2025:Key Participant Carl Zeiss Meditec AG, Leica MicrosystemsCell Imaging Market

San Francisco, 24 December 2018,  Live Cell Imaging Market Analysis By Product, Application, Technology (Time lapse Microscopy, Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High Content Screening), & Segment Forecasts, 2018 – 2025

The global live cell imaging market is expected to reach USD 9.0 billion by 2025, according to a new report by Grand View Research, Inc. Rising popularity of kinetic research over fixed cellular analysis is the key driver. Addition of dyes and reagents alter the cell behavior, mostly in a negative manner, which does not showcase the natural course of action of the cellular functions. Understanding the cellular behavior in its natural state is crucial in drug discovery and targeted drug therapy. This, in turn, increases the need for live cell imaging, thus boosting the market.

In a survey by Drug Discovery World Spring, almost 21% researchers prefer & use live cell imaging and 31% plan to use it in the future. Moreover, 38% of the respondents were interested in using live cell kinetic HCS imaging in the future. The most important feature for researchers is the ability to automate the incubation and image capturing of any live cell analyzer. Secondly, they also give importance to viable cell-tracking ability of the equipment. Further development in the technology of equipment is expected to fulfill these criteria and boost the utility of the same over the forecast period.

Development in delivering probes in living cells, targeting organelles, and proteins using some of the techniques has increased use and adoption of live cell imaging in research and other applications. With improved fluorescent probes, the techniques such as Fluorescence Resonance Energy Transfer (FRET) share a majority of the share.

Access Full Research Report On Live Cell Imaging Market  Analysis:
www.grandviewresearch.com/industry-analysis/live-cell-imaging-market

Further Key Findings From The Report Suggest:

·         Equipment dominated the product segment in 2016. The current system, although of great potential are still expected to perform better over the next few years. The general trend is to make the instruments compact and integrated for end-to-end processing.

·         Cell biology dominated the application with more than 30% of the shares and was closely followed by developmental biology. Stem cell and drug discovery are the upcoming fields to apply live cell imaging in the research.

·         North America dominated due to its high investment rate and technologically sound infrastructure. The research firms present in this region are technologically aware, hence, readily invest in high cost equipment.

·         Asia Pacific is expected to show fastest growth over the forecast period due to increasing application of these imaging techniques in drug discovery and personalized medicine.

·         Key players includes Carl Zeiss Meditec AG; Leica Microsystems; Nikon Corporation; Becton, Dickinson and Company; GE Healthcare; Olympus Corporation; Thermo Fisher Scientific Inc.; Sigma-Aldrich Corporation; PerkinElmer, Inc.; and Molecular Devices, LLC

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global live cell imaging market on the basis of product, application, technology, and region:

Live Cell Imaging Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Equipment

·         Consumable

·         Software

Live Cell Imaging Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Cell Biology

·         Developmental Biology

·         Stem Cell & Drug Discovery

·         Others

Live Cell Imaging Technology Outlook (Revenue, USD Million, 2014 - 2025)

·         Time lapse Microscopy

·         Fluorescence recovery after photobleaching (FRAP)

·         Fluorescence resonance energy transfer (FRET)

·         High content screening (HCS)

·         Others

Live Cell Imaging Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    China

o    Japan

·         Latin America

o    Brazil

o    Mexico

·         MEA

o    South Africa 

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-live-cell-imaging-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

Surgical Retractors Market Expected To Trigger A Revenue Increase To 1.81 Billion By 2025:Key Participant B.Braun, Medtronic

San Francisco, 22 November 2018, The global surgical retractors market size is expected to reach USD 1.81 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.2% CAGR over the forecast period. The market is primarily driven by unprecedented upsurge in surgical volume over the past few years. According to data published by WHO, the global surgical volume was estimated at 312.9 million in 2012 from 226.4 million in 2004. The statistics also showed that the mean global surgical rate is approximately 4,469 surgeries per 100,000 population per year. These numbers exemplify the widening scope of surgery and adoption of retractors.

Increase in number of cesarean surgeries has fueled demand for C-section retractors. As per the American Medical Association, adoption rate of cesarean surgeries is around 19.0% globally. Technological developments, such as automation in surgical instruments, are improving minimally invasive surgeries, thus creating high growth potential for the market. For instance, advent of atraumatic laparoscopic retractors and 3D retractors has ensured greater safety during surgeries and reduced post-operative complications.

Access Full Research Report On Surgical Retractors Market Analysis:www.grandviewresearch.com/industry-analysis/surgical-retractors-market

Further key findings from the report suggest:

·         By type, hand-held retractors accounted for the largest share in 2017 as a result of advantages such as low cost of product handling, storage, and maintenance. Self-retaining retractors are predicted to exhibit lucrative growth owing to greater convenience associated with them

·         On the basis of product, orthopedic retractors held a considerable share in 2017 owing to increasing incidence of orthopedic disorders in bariatric and geriatric patients

·         Obstetrics and gynecology dominated the market based on application owing to upsurge in number of C-section surgeries and gynecological preventive examinations globally

·         In 2017, North America held a substantial market share owing to growing prevalence of chronic diseases and presence of highly advanced medical infrastructure. Adoption of technologically advanced products is also presenting high growth prospects

·         The market in Asia Pacific is anticipated to witness significant growth owing to improving healthcare systems, rising healthcare expenditure, and growing awareness

·         Key companies include Teleflex, Johnson & Johnson, B.Braun, Medtronic, Thompson Surgical, and Becton, Dickinson and Company

·         The market is highly competitive with key participants consistently deploying strategies such as mergers and acquisitions to gain competitive advantage. For instance, in April 2017, Teleflex acquired Pyng Medical to gain a leadership position and expand its product portfolio.

Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global surgical retractors market on the basis of type, product, application, end use, and region:

Surgical Retractors Type Outlook (Revenue, USD Million, 2014 - 2025)

·         Hand-held

·         Self-retaining

Surgical Retractors Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Abdominal

·         Finger

·         Nerve

·         Orthopedic

·         Rectal

·         Thoracic

·         Ribbon

·         Others

Surgical Retractors Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Neurosurgery

·         Wound Closure

·         Reconstructive Surgery

·         Cardiovascular

·         Orthopedic

·         Obstetrics & Gynecology

·         Others

Surgical Retractors End-use Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals

·         Ambulatory Surgical Centers

·         Others

Surgical Retractors Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    U.K.

o    Germany

·         Asia Pacific

o    Japan

o    China

o    India

·         Latin America

o    Brazil

o    Mexico

·         Middle East & Africa

o    South Africa

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-surgical-retractors-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/